Mission Bio, Inc. — Form D
Mission Bio, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-06-23. The offering totals $13.3M, of which $13.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-06-23
- Form: D
- Accession: 0001709830-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $13.3M
- Amount sold: $13.3M
- Investors: 54
- Date of first sale: 2017-06-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-289318
Issuer
- Name: Mission Bio, Inc.
- CIK: 0001709830
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 6000 SHORELINE COURT, SOUTH SAN FRANCISCO, CA, 94080
- Phone: (415) 854-0058
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Charles Silver | Director | San Carlos, CA |
| Charles Silver | Executive Officer | San Carlos, CA |
| Urshit Parikh | Director | Santa Clara, CA |
| Brock Siegel, Ph.D. | Director | South San Francisco, CA |
| Adam Abate, Ph.D. | Director | South San Francisco, CA |
| Maneesh Jain, Ph.D. | Director | South San Francisco, CA |
| Allison Ballmer | Director | South San Francisco, CA |
| Paul Billings, M.D., Ph.D. | Director | South San Francisco, CA |
Other filings by this issuer (1)
More